# Protalix BioTherapeutics, Inc.: Form 8-K, filed Dec 22, 2009

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2009-12-22
- Accepted by EDGAR: Dec 22, 2009, 16:30 ET
- Period: 2009-12-17
- Accession: 0000950123-09-072718
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000095012309072718/y02773e8vk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000095012309072718/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000095012309072718/y02773e8vk.htm

Filed Dec 22, 2009.
Source: SEC EDGAR, the filing index for accession 0000950123-09-072718. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
